ANI Pharmaceuticals Inc (ANIP)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 584 | 46,971 | -25,064 | -32,512 | -16,064 |
| Revenue | US$ in thousands | 614,376 | 486,816 | 316,385 | 216,136 | 208,475 |
| Operating profit margin | 0.10% | 9.65% | -7.92% | -15.04% | -7.71% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $584K ÷ $614,376K
= 0.10%
ANI Pharmaceuticals Inc's operating profit margin has shown fluctuation over the past five years. In December 2020, the operating profit margin was at -7.71%, indicating a negative margin, which worsened to -15.04% by December 2021. However, there was a slight improvement in December 2022 with a margin of -7.92%.
The trend took a positive turn in December 2023, when the operating profit margin increased significantly to 9.65%, reflecting a strong improvement in profitability. However, by December 2024, the margin decreased to 0.10%, suggesting a slight dip in profitability compared to the previous year.
Overall, ANI Pharmaceuticals Inc experienced a mix of negative and positive operating profit margins over the five-year period, with a notable improvement in 2023 followed by a slight decline in 2024. It would be important for the company to focus on sustaining and enhancing its profitability in the future to ensure long-term financial health and success.
Peer comparison
Dec 31, 2024